E Therapeutics (ETX)

 

ETX Share PerformanceMore

52 week high13.2500 22/06/17
52 week low6.0000 01/06/17
52 week change 1.5000 (17.65%)
4 week volume8,906,056 24/12/17

Latest NewsMore

e-Therapeutics enters two AI collaborations

e-Therapeutics is to collaborate with Intellegens and Biorelate to enhance and extend its artificial intelligence technology ca...

E-Therapeutics enters two AI collaborations

RNS Number: 8093B e-Therapeutics plc 15 January 2018 e-Therapeutics ('e-Therapeutics' or the 'Company') e-Therapeutics to collaborate with Intellegens and Biorelate to enhance and extend its AI technology capabilities Oxford, UK, 15 January 2018: e-Therapeutics , a company pioneering the use of Network-Driven Drug Discovery (NDD) to create new and better drugs...

Director/PDMR Shareholding

RNS Number: 7794A e-Therapeutics plc 03 January 2018 E-THERAPEUTICS PLC ("e-Therapeutics" or the "Company") NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND ISSUE OF EQUITY Oxford, UK, 3 January 2018 - e-Therapeutics plc (AIM: ETX), the drug discover...

Holding(s) in Company

RNS Number: 6798Z e-Therapeutics plc 18 December 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: e-Therapeutics PL...

Director Deals - e-Therapeutics PLC (ETX)

Iain Ross, Chairman, bought 200,000 shares in the company on the 15th December 2017 at a price of 8.90p. The Director now...

Director Deals - e-Therapeutics PLC (ETX)

Dr Raymond Barlow, Chief Executive Officer, bought 100,000 shares in the company on the 15th December 2017 at a price...

Director Deals - e-Therapeutics PLC (ETX)

Christine Soden, Non Executive Director, bought 120,000 shares in the company on the 15th December 2017 at a price of 8.9...

Director Deals - e-Therapeutics PLC (ETX)

Prof Trevor Jones, Non Executive Director, bought 50,000 shares in the company on the 15th December 2017 at a price of 8...

Fundamental DataMore

EPS-4.91
Dividend yield0 %

Latest discussion posts More

  • Q1 2017 blog update - ETX

    Q1 2017 blog weekly ETX chart update - notes under each chart: http://bonker99.com/Blogs
    10-Feb-2017
    Bonker
  • ETX chart

    http://bonker99.com/charts
    6-Feb-2017
    Bonker
  • Results

    RNS available at company's website. although seems to be missing in III ...
    22-Mar-2016
    nk1999

Users' HoldingsMore

Users who hold E Therapeutics also hold..

Codes & Symbols

ISINGB00B2823H99
SymbolsETX, LSE:ETX, ETX.L, ETX:LN, LON:ETX, XLON:ETX

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account